Evidence map›Paper›PMID 10567564›Full record

ArticleMolecular and cellular biology1999

Coexamination of site-specific transcription factor binding and promoter activity in living cells.

K E Boyd, P J Farnham

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 165 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

K E BoydMcArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA.
P J Farnham
University of Wisconsin–Madison · US

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
TRANSCRIPTIONAL REGULATION OF GROWTH-RELATED GENESR01CA045240 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FARNHAM, PEGGY J · 1992 to 2011
$3.4M
STOREROOM AND MATERIALS ACQUISITION LABORATORYP30CA007175 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI PITOT, JR., HENRY C · 1985 to 2000
$2.4M
TRANSCRIPTIONAL REGULATION OF GROWTH-RELATED GENESR29CA045240 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FARNHAM, PEGGY J · 1987 to 1991
–
NCI NIH HHS CA07175NCI NIH HHS CA09135NCI NIH HHS CA45240NCI NIH HHS R01 CA045240NCI NIH HHS T32 CA009135
6 · The paper itself

Abstract

Previously, we have used a chromatin cross-linking and immunoprecipitation protocol for the analysis of Myc and USF binding to the cad promoter. The adaptation of this technique for the study of mammalian transcription factors was a big step forward in the analysis of transcription factor family member specificity, allowing for the first time a definitive knowledge of which factor binds to a promoter region under normal physiological conditions. However, due to limitations of the assay, our previous studies could not definitively prove that both Myc and USF bound to the exact same site on the cad promoter, nor could we directly correlate loss of in vivo binding of a particular factor with loss of transcriptional activity. Therefore, we have further modified the chromatin immunoprecipitation protocol to alleviate these problems. We have now shown that it is possible to coexamine growth-regulated transcriptional activity and promoter occupancy by using stably integrated promoter constructs. We show that both Myc and USF bind to the exact same E box on the cad promoter, suggesting that competition between these two factors for a single site occurs in living cells. We also find that cad promoter constructs that retain USF binding but lose Myc binding in vivo no longer display an increase in transcriptional activity in mid- to late G(1) phase of the cell cycle. Finally, we propose that cell cycle-regulated transcriptional activation of the cad promoter may be a stochastic, rather than a predetermined, process.

Indexed as

DNA-Binding ProteinsPhosphopyruvate HydratasePromoter Regions, GeneticTumor Suppressor Proteins3T3 CellsAnimalsBinding SitesBiomarkers, TumorMiceNeoplasm ProteinsTranscription FactorsUpstream Stimulatory FactorsBiomarkers, TumorDNA-Binding ProteinsENO1 protein, humanNeoplasm ProteinsPhosphopyruvate HydrataseTranscription FactorsTumor Suppressor ProteinsUpstream Stimulatory FactorsUsf1 protein, mouse

Identifiers

PMID10567564
PMCPMC84934
OpenAlexW2124963418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.